|
Based on the information provided, no conclusions can be made.As reported, the patient was diagnosed with cyanotic in left nipple and was treated with medication.Medical affairs has assessed the patient¿s cyanotic as being serious and likely related to the study device.Review of the device history records confirmed the device was manufactured to specification.This mdr report is related to a retrospective study conducted to proactively gather real-world evidence on the use and safety of the p4hb product family, including galaflex scaffold, galaflex 3d, and galaflex 3dr. all safety events from the study are adjudicated by the bd medical monitor for an independent assessment of severity and relatedness. in an abundance of caution, events for which relatedness cannot be ruled out are processed for mdr reporting.Not returned.
|
|
Per clinical trial (b)(6): on (b)(6) 2019, patient underwent bilateral revision augmentation; other (removal of implants) using a full vertical and horizontal t incision.2 pieces of galashape (galaflex 3d) were used.Concomitant procedures included mastopexy/autoaugmentation.On (b)(6) 2019, cyanosis of left nipple was reported.Patient was treated with medication (nitro paste).Resolved without sequelae on (b)(6) 2019.Review by medical affairs identifies the cyanosis as likely related to the device and serious.
|